https://www.live-feeds.com/feed/meeting-highlights-from-the-committee-for-medicinal-products-for-human-use-chmp-22-25-june-2026Continuously updated, source-cited coverage. https://www.live-feeds.com/feed/meeting-highlights-from-the-committee-for-medicinal-products-for-human-use-chmp-22-25-june-2026https://www.live-feeds.com/feed/meeting-highlights-from-the-committee-for-medicinal-products-for-human-use-chmp-22-25-june-2026#u22155Fri, 03 Jul 2026 02:22:15 +0000The Committee for Medicinal Products for Human Use met from 22-25 June 2026 to review medicinal products. The panel recommended six new drugs for approval and extended therapeutic indications for 12 others. Notable recommendations include a new treatment for chronic lymphocytic leukemia.What's confirmed:The CHMP recommended the approval of Jaypirca (pirtobrutinib) in the European Union for adults with chronic lymphocytic leukemia across all lines of therapy.The CHMP met from 22-25 June 2026.The CHMP recommended the approval of six new drugs and extended therapeutic indications for 12 other med